Hiroaki Itamochi

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Placebo Controlled

Top Venues

Journal of gynecologic oncology

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Shin Nishio, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ai Kato, Ajit Suri, Toshiaki Yasuoka, Kazuhiro Takehara
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study. Journal of gynecologic oncology (2024)
Shin Nishio, Kan Yonemori, Tomoka Usami, Shinichiro Minobe, Mayu Yunokawa, Takashi Iwata, Aikou Okamoto, Yoichi Aoki, Hiroaki Itamochi, Munetaka Takekuma, Kenichi Harano, Keiko Yamamoto, Takeshi Maruko, Hiroyuki Ugai, Cumhur Tekin, Nicoletta Colombo, Keiichi Fujiwara, Kosei Hasegawa, Kimio Ushijima
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826. Cancer science 113 (11) (2022)
Hiroaki Itamochi, Hisanori Ariga, Kiyoto Shiga, Noriyuki Uesugi, Tamotsu Sugai
Primary rhabdomyosarcoma of the ethmoid sinus with orbital extension and metastasis to the pancreatic body. Clinical case reports 10 (8) (2021)
Kazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Kimio Ushijma, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ajit Suri, Hiroaki Itamochi, Nobuhiro Takeshima
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer. Journal of gynecologic oncology 32 (2) (2021)
Bart Kolendowski, Yudith Ramos Valdes, Hal Hirte, Hiroaki Itamochi, Wonjae Lee, Mark Carey, Trevor G Shepherd, Gabriel E DiMattia
Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C. Cells 9 (11) (2020)
Toru Sugiyama, Satoshi Takeuchi, Hiroaki Itamochi
Surgical management of non-invasive uterine clear cell carcinoma. Journal of gynecologic oncology 28 (4) (2017)